Tag: chemotherapy

1. First line treatment with pembrolizumab-chemotherapy showed significant improvement in progression-free survival compared to chemotherapy alone in patients with metastatic triple-negative breast cancer and a CPS of 10 or more. 2. There was no significant increase in adverse events or death with the addition of pembrolizumab to standard first-line chemotherapy.  Evidence...
1. First line treatment with pembrolizumab-chemotherapy showed significant improvement in progression-free survival compared to chemotherapy alone in patients with metastatic triple-negative breast cancer and a CPS of 10 or more. 2. There was no significant increase in adverse events or death with the addition of pembrolizumab to standard first-line chemotherapy.  Evidence...